Exelon
EXC
41.49
-0.19
-0.46%
Exelon
US · EXC
#536 by market cap
Listed 1970
41.49
-0.19
-0.46%
Live - 5344 symbols - heartbeat 528s ago
· 2026-10-08 07:17
Pre-market
41.50
+0.02%
After-hours
41.49
0.00%
- Market cap
- 42.83B
- P/E (TTM)i
- 15.25
- P/Bi
- 1.44
- EPSi
- 2.73
- Div yieldi
- 3.95%
- 52W posi
- 18%
Reader sentiment
Are you bullish or bearish on EXC?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 0.73, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +5.34% YoY
Margins
- Gross margin
- 42.93%
- Operating margin
- 21.21%
- Net margin
- 11.41%
Key ratios & quality
- Enterprise valuei
- 92.28B
- PEG ratioi
- 1.80
- Altman Z-Scorei
- 0.73
PEG uses trailing P/E against the 3-year net income growth rate (8.45%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 35.98B | 34.44B | 33.04B | 17.94B | 19.08B | 21.73B | 23.03B | 24.26B |
| Gross profit | 9.97B | 10.33B | 9.53B | 7.01B | 8.03B | 8.93B | 9.41B | 10.41B |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 3.84B | 4.34B | 2.80B | 2.68B | 3.32B | 4.01B | 4.31B | 5.15B |
| Pretax profit | 2.23B | 3.99B | 2.33B | 1.65B | 2.40B | 2.70B | 2.67B | 3.29B |
| Tax | 118.00M | 774.00M | 373.00M | 38.00M | 349.00M | 374.00M | 207.00M | 523.00M |
| Net profit | 2.08B | 3.03B | 1.95B | 1.83B | 2.17B | 2.33B | 2.46B | 2.77B |
| Basic EPS | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 3 |
| Diluted EPS | 2.07 | 3.01 | 2.01 | 1.74 | 2.20 | 2.34 | 2.45 | 2.73 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 6.71B | 5.43B | 6.71B | 5.41B | 7.24B | 5.97B |
| Gross profit | 2.85B | 2.21B | 2.84B | 2.52B | 3.00B | 2.37B |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.54B | 925.00M | 1.50B | 1.18B | 1.61B | 979.00M |
| Pretax profit | 1.08B | 461.00M | 1.03B | 721.00M | 1.12B | 495.00M |
| Tax | 170.00M | 70.00M | 155.00M | 127.00M | 200.00M | 99.00M |
| Net profit | 908.00M | 391.00M | 875.00M | 594.00M | 919.00M | 396.00M |
| Basic EPS | 1 | 0 | 1 | 1 | 1 | 0 |
| Diluted EPS | 0.90 | 0.39 | 0.86 | 0.58 | 0.90 | 0.39 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 13.33B | 12.04B | 12.56B | 13.96B | 7.34B | 8.09B | 8.38B | 9.55B |
| Cash & ST investments | 1.35B | 587.00M | 663.00M | 672.00M | 407.00M | 445.00M | 357.00M | 626.00M |
| Inventory | 1.69B | 1.77B | 1.72B | 581.00M | 755.00M | 801.00M | 853.00M | 868.00M |
| Total assets | 119.63B | 124.98B | 129.32B | 133.01B | 95.35B | 101.86B | 107.78B | 116.57B |
| Total current liabilities | 11.40B | 14.19B | 12.77B | 16.11B | 10.61B | 9.90B | 9.61B | 10.33B |
| Short-term debt | 2.06B | 6.08B | 3.85B | 3.40B | 4.39B | 3.93B | 3.31B | 2.28B |
| Long-term debt | 34.47B | 31.72B | 35.48B | 31.14B | 35.66B | 40.08B | 43.34B | 47.80B |
| Total liabilities | 86,587,000,000.00 | 90,404,000,000.00 | 94,449,000,000.00 | 98,218,000,000.00 | 70,605,000,000.00 | 76,101,000,000.00 | 80,863,000,000.00 | 87,772,000,000.00 |
| Total equity | 33.05B | 34.57B | 34.87B | 34.80B | 24.74B | 25.76B | 26.92B | 28.80B |
| Retained earnings | 14.74B | 16.27B | 16.74B | 16.94B | 4.60B | 5.49B | 6.43B | 7.58B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 8.80B | 8.68B | 9.23B | 9.55B | 9.00B | 9.80B |
| Cash & ST investments | 1.00B | 724.00M | 1.53B | 626.00M | 713.00M | 1.81B |
| Inventory | 833.00M | 868.00M | 888.00M | 868.00M | 846.00M | 894.00M |
| Total assets | 109.48B | 111.15B | 113.54B | 116.57B | 117.55B | 120.51B |
| Total current liabilities | 8.10B | 9.16B | 9.83B | 10.33B | 9.59B | 9.01B |
| Short-term debt | 2.54B | 2.93B | 3.25B | 2.28B | 2.99B | 1.97B |
| Long-term debt | 45.73B | 45.92B | 46.67B | 47.80B | 48.25B | 50.70B |
| Total liabilities | 81,877,000,000.00 | 83,527,000,000.00 | 85,426,000,000.00 | 87,772,000,000.00 | 88,230,000,000.00 | 90,807,000,000.00 |
| Total equity | 27.61B | 27.62B | 28.11B | 28.80B | 29.32B | 29.70B |
| Retained earnings | 6.93B | 6.92B | 7.39B | 7.58B | 8.07B | 8.03B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 8.64B | 6.66B | 4.24B | 3.01B | 4.87B | 4.70B | 5.57B | 6.25B |
| Depreciation & amortization | 5.97B | 5.78B | 6.53B | 6.43B | 2.77B | 2.79B | 2.92B | 3.05B |
| Free cash flow | 1.05B | -589.00M | -3.81B | -4.97B | -2.28B | -2.71B | -1.53B | -2.28B |
| Dividends paid | -1.33B | -1.41B | -1.49B | -1.50B | -1.33B | -1.43B | -1.52B | -1.62B |
| Stock buybacks / issuance | -- | -- | -- | 0 | 563.00M | 140.00M | 148.00M | 691.00M |
| Ending cash balance | 1.78B | 1.12B | 1.17B | 1.62B | 1.09B | 1.10B | 939.00M | 1.20B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 1.20B | 1.51B | 2.30B | 1.24B | 1.72B | 1.95B |
| Depreciation & amortization | 752.00M | 757.00M | 764.00M | 773.00M | 794.00M | 811.00M |
| Free cash flow | -746.00M | -502.00M | 163.00M | -1.19B | -634.00M | -255.00M |
| Dividends paid | -403.00M | -405.00M | -404.00M | -405.00M | -430.00M | -430.00M |
| Stock buybacks / issuance | 173.00M | 0 | 0 | 518.00M | 0 | 382.00M |
| Ending cash balance | 1.58B | 1.25B | 2.10B | 1.20B | 1.30B | 2.43B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 6.63 | 9.32 | 6.06 | 5.09 | 7.34 | 9.22 | 9.34 | 9.94 |
| ROA %i | 1.70 | 2.40 | 1.54 | 1.30 | 1.90 | 2.36 | 2.35 | 2.47 |
| ROIC %i | 5.24 | 6.17 | 4.70 | 4.36 | 4.81 | 5.67 | 5.90 | 5.98 |
| 5-year avg ROE %i | 8.21 | 8.64 | 7.98 | 8.13 | 6.89 | 7.41 | 7.41 | 8.19 |
| EBIT margin %i | 10.52 | 16.26 | 12.01 | 10.40 | 20.18 | 20.39 | 19.89 | 22.33 |
| FCF / sales %i | 2.92 | -- | -- | -- | -- | -- | -- | -- |
| Current ratioi | 1.17 | 0.85 | 0.98 | 0.87 | 0.69 | 0.82 | 0.87 | 0.92 |
| Quick ratioi | 0.64 | 0.48 | 0.41 | 0.22 | 0.37 | 0.38 | 0.43 | 0.55 |
| Debt / assetsi | 30.53 | 30.24 | 30.42 | 25.97 | 42.00 | 43.21 | 43.28 | 42.96 |
| LT debt / equityi | 112.11 | 98.43 | 108.89 | 90.54 | 144.12 | 155.63 | 160.98 | 165.99 |
| Interest coveragei | 2.44 | 3.47 | 2.43 | 2.41 | 2.66 | 2.56 | 2.39 | 2.55 |
| Revenue CAGR (3Y) %i | 6.91 | 3.16 | -0.52 | -20.71 | -17.87 | -13.04 | 8.68 | 8.34 |
| Net income CAGR (3Y) %i | -4.04 | 37.84 | -19.61 | -5.24 | -9.59 | 5.85 | 12.98 | 8.45 |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 10.10 | 9.87 | 10.31 | 9.94 | 9.76 | 9.71 |
| ROA %i | 2.55 | 2.45 | 2.57 | 2.47 | 2.45 | 2.40 |
| ROIC %i | 6.06 | 5.96 | 6.09 | 5.98 | 5.87 | 5.81 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 21.01 | 21.02 | 21.84 | 22.33 | 22.21 | 22.04 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 1.09 | 0.95 | 0.94 | 0.92 | 0.94 | 1.09 |
| Quick ratioi | 0.62 | 0.53 | 0.56 | 0.55 | 0.56 | 0.67 |
| Debt / assetsi | 44.09 | 43.95 | 43.97 | 42.96 | 43.59 | 43.71 |
| LT debt / equityi | 165.65 | 166.25 | 166.02 | 165.99 | 164.59 | 170.73 |
| Interest coveragei | 2.55 | 2.49 | 2.60 | 2.55 | 2.53 | 2.52 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Commonwealth Edison Company (ComEd) is the largest reported line at 33.27% of revenue, across 6 reported segments.
- No single line clears half of revenue; Pepco Holdings LLC (PHI) is next at 28.69%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Commonwealth Edison Company (ComEd)33.27%
Pepco Holdings LLC (PHI)28.69%
Baltimore Gas and Electric Company (BGE)20.41%
PECO Energy Company (PECO)17.80%
Other7.89%
Quote time 2026-10-08 07:17:03 · For reference only, not investment advice and not tailored to your situation.